<SEC-DOCUMENT>0001564590-19-009342-index.html : 20190326 <SEC-HEADER>0001564590-19-009342.hdr.sgml : 20190326 <ACCEPTANCE-DATETIME>20190326161042 ACCESSION NUMBER: 0001564590-19-009342 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20190326 DATE AS OF CHANGE: 20190326 EFFECTIVENESS DATE: 20190326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-230504 FILM NUMBER: 19705407 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>phas-s8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: phas-s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>phas-ex51_7.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: phas-ex51_7.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>phas-ex231_6.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: phas-ex231_6.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>gfmydxp1nmuw000001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: gfmydxp1nmuw000001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>gfmydxp1nmuw000002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: gfmydxp1nmuw000002.jpg
</DOCUMENT> </SEC-DOCUMENT>